GOODWILL AND INTANGIBLE ASSETS

3 Months Ended

Jan. 24, 2016

NOTE DGOODWILL AND INTANGIBLE ASSETS

The carrying amounts of goodwill for the quarter ended January 24, 2016, are presented in the table below. The reduction during the first quarter is due to purchase accounting adjustments for Applegate.

(in thousands)	Grocery Products		Refrigerated Foods		JOTS		Specialty Foods		International & Other		Total

Balance as of October 25, 2015	$	322,421	$	584,684	$	203,214	$	456,416	$	132,749	$	1,699,484
Purchase adjustment	-		(123)		-		-		-		(123)

Balance as of January 24, 2016	$	322,421	$	584,561	$	203,214	$	456,416	$	132,749	$	1,699,361

The gross carrying amount and accumulated amortization for definite-lived intangible assets are presented in the table below.

	January 24, 2016				October 25, 2015
(in thousands)	Gross Carrying Amount		Accumulated Amortization		Gross Carrying Amount		Accumulated Amortization

Customer lists/relationships	$	83,190	$	(15,699)	$	83,190	$	(13,939)
Formulas and recipes	7,490		(7,117)		7,490		(6,865)
Proprietary software and technology	1,010		(901)		7,010		(6,901)
Other intangibles	2,120		(1,083)		2,370		(1,195)

Total	$	93,810	$	(24,800)	$	100,060	$	(28,900)

Amortization expense was $2.1 million for the quarters ended January 24, 2016 and January 25, 2015.

Estimated annual amortization expense for the five fiscal years after October 25, 2015, is as follows:

(in millions)
2016		$ 8.2
2017		7.6
2018		7.0
2019		7.0
2020		6.8

The carrying amounts for indefinite-lived intangible assets are presented in the table below.

(in thousands)	January 24, 2016		October 25, 2015

Brands/tradenames/trademarks	$	748,075	$	748,075
Other intangibles	7,984		7,984

Total	$	756,059	$	756,059

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References + Details